Methylprednisolone for the treatment of acute spinal cord injury: Point

Neurosurgery

Volumn 61, Issue , 2007, Pages 32-35

  Hurlbert, R John ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; DRUG THERAPY; NEUROPROTECTIVE AGENT;

CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; SPINAL CORD INJURY; STEROID THERAPY; THERAPY EFFECT; TREATMENT OUTCOME; CLINICAL TRIAL (TOPIC); DRUG THERAPY; GASTROINTESTINAL HEMORRHAGE; HYPERGLYCEMIA; MORTALITY; PNEUMONIA; RESPIRATORY TRACT INFECTION; SPINAL CORD DECOMPRESSION; SPINAL CORD INJURIES; WOUND INFECTION;

CLINICAL TRIALS AS TOPIC; DRUG THERAPY; HUMANS; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; SPINAL CORD INJURIES; THERAPEUTIC USE;

EID: 84964301724     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000393     Document Type: Conference Paper

References (24)

1. Walters BC, Hadley MN, Hurlbert RJ, et al. Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2013;72(suppl 2):1-259.
2. Bracken MB, Collins WF, Freeman DF, et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA. 1984;251(1):45-52.
3. Bracken MB, Shepard MJ, Hellenbrand KG, et al. Methylprednisolone and neurological function 1 year after spinal cord injury: results of the National Acute Spinal Cord Injury Study. J Neurosurg. 1985;63(5):704-713.
4. Bracken MB, Shepard MJ, Collins WF, et al. A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322(20):1405-1411.
5. Bracken MB, Shepard MJ, Collins WF Jr, et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. J Neurosurg. 1992; 76(1):23-31.
6. Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA. 1997;277(20):1597-1604.
7. Bracken MB, Shepard MJ, Holford TR, et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow-up. Results of the third National Acute Spoinal Cord Injury randomized controlled trial. J Neurosurg. 1998;89(5):699-706.
8. Otani K, Abe H, Kadoya S, et al. Beneficial effect of methylprednisolone sodium succinate in the treatment of acute spinal cord injury [translated version]. Sekitsu Sekizui. 1994;7:633-647.
9. Pointillart V, Petitjean ME, Wiart L, et al. Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord. 2000;38(2):71-76.
10. Galandiuk S, Raque G, Appel S, Polk HJ Jr. The two-edged sword of large-dose steroids for spinal cord trauma. Ann Surg. 1993;218(4):419-427.
11. Qian T, Guo X, Levi AD, Vanni S, Shebert RT, Sipski ML. High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients. Spinal Cord. 2005;43(4):199-203.
12. Ito Y, Sugimoto Y, Tomioka M, Kai N, Tanaka M. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical cord injury?: a prospective study about neurological recovery and early complications. Spine (Phila Pa 1976). 2009;34(20):2121-2124.
13. Kiwerski JE. Application of dexamethasone in the treatment of acute spinal cord injury. Injury. 1993;24(7):457-460.
14. Prendergast MR, Saxe JM, Ledgerwood AM, Lucas CE, Lucas WF. Massive steroids do not reduce the zone of injury after penetrating spinal cord injury. J Trauma. 1994;37(4):576-579.
15. George ER, Scholten DJ, Buechler CM, Jordan-Tibbs J, Mattice C, Albrecht RM. Failure of methylprednisolone to improve the outcome of spinal cord injuries. Am Surg. 1995;61(8):659-663.
16. Gerhart KA, Johnson RL, Menconi J, Hoffman RE, Lammertse DP. Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Paraplegia. 1995;33(6):316-321.
17. Poynton AR, O'Farrell DA, Shannon F, Murray P, McManus F, Walsh MG. An evaluation of the factors affecting neurological recovery following spinal cord injury. Injury. 1997;28(8):545-548.
18. Pollard ME, Apple DF. Factors associated with improved neurological outcomes in patients with incomplete tetraplegia. Spine (Phila Pa 1976). 2003;28(1):33-39.
19. Aito S, D'Andrea M, Werhagen L. Spinal cord injuries due to diving accidents. Spinal Cord. 2005;43(2):109-116.
20. Tsutsumi S, Ueta T, Shiba K, Yamamoto S, Takagishi K. Effects of second national acute spinal cord injury study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine (Phila Pa 1976). 2006;31(26):2992-2996.
21. Lee HC, Cho DY, Lee WY, Chuang HC. Pitfalls in treatment of acute cervical spinal cord injury using high-dose methylprednisolone: a retrospect audit of 111 patients. Surg Neurol. 2007;68(26):37-42.
22. Suberviola B, González-Castro A, Llorca J, Ortiz-Melón F, Miñambres E. Early complications of high-dose methylprednisolone in acute spinal cord injury patients. Injury. 2008;39(7):748-752.
23. Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila Pa 1976). 2001;26(4): 426-430.
24. Gerndt SJ, Rodriguez JL, Pawlik JW, et al. Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma. 1997;42(2):279-284.